^ESCT1348323	Administration of first dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
^ESCT1348324	Administration of first dose of 2019-nCoV (novel coronavirus) vaccine
COCO138186NEMIS	COVID-19 mRNA Vaccine BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer-BioNTech) (Pfizer-BioNTech)
^ESCT1348325	Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
^ESCT1348326	Administration of second dose of 2019-nCoV (novel coronavirus) vaccine
^ESCT1428354	Administration of third dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
^ESCT1428342	Administration of fourth dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
^ESCT1428348	Administration of fifth dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
^ESCT1348298	SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination
^ESCT1348301	COVID-19 vaccination
^ESCT1299050	2019-nCoV (novel coronavirus) vaccination
^ESCT1301222	SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination
CODI138564NEMIS	Covid-19 mRna (nucleoside modified) Vaccine Moderna  Dispersion for injection  0.1 mg/0.5 ml dose, multidose vial
TASO138184NEMIS	Covid-19 Vaccine AstraZeneca (ChAdOx1 S recombinant)  Solution for injection  5x10 billion viral particle/0.5 ml multidose vial
PCSDT18491_1375	Administration of first dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
PCSDT18491_1376	Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
PCSDT18491_716	Administration of second dose of SARS-CoV-2 vacc
PCSDT18491_903	Administration of first dose of SARS-CoV-2 vacccine
PCSDT3370_2254	2019-nCoV (novel coronavirus) vaccination
PCSDT3919_2185	Administration of first dose of SARS-CoV-2 vacccine
PCSDT3919_662	Administration of second dose of SARS-CoV-2 vacc
PCSDT4803_1723	2019-nCoV (novel coronavirus) vaccination
PCSDT5823_2264	Administration of second dose of SARS-CoV-2 vacc
PCSDT5823_2757	Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
PCSDT5823_2902	Administration of first dose of SARS-CoV-2 vacccine
^ESCT1348300	Severe acute respiratory syndrome coronavirus 2 vaccination
ASSO138368NEMIS	COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd)
COCO141057NEMIS	Comirnaty Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd)
COSO141059NEMIS	COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India)
COSU138776NEMIS	COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd)
COSU138943NEMIS	COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials (Baxter Oncology GmbH)
COSU141008NEMIS	CoronaVac COVID-19 Vaccine (adjuvanted) 600U/0.5ml dose suspension for injection vials (Sinovac Life Sciences)
COSU141037NEMIS	COVID-19 Vaccine Sinopharm BIBP (inactivated adjuvanted) 6.5U/0.5ml dose suspension for injection vials (Beijing Institute of Biological Products)
^ESCT1299051	Wuhan 2019-nCoV (novel coronavirus) vaccination
^ESCT1299052	2019 novel coronavirus vaccination
^ESCT1348299	2019 novel coronavirus vaccination
^ESCT1348302	2019-nCoV (novel coronavirus) vaccination
^ESCT1402904	COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd)
^ESCT1402911	COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd)
^ESCT1403901	Astute 100,000,000,000 (100 billion) viral particles/0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd)
^ESCT1404736	COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5mL dose dispersion for injection multidose vials (Moderna, Inc)
^ESCT1405128	COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials (Valneva UK Ltd)
^ESCT1418812	COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials (Baxter Oncology GmbH)
^ESCT1421492	SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen vaccination
^ESCT1421493	COVID-19 antigen immunisation
^ESCT1421494	2019 novel coronavirus antigen immunisation
^ESCT1421495	2019 novel coronavirus antigen vaccination
^ESCT1421496	COVID-19 antigen vaccination
^ESCT1421497	Severe acute respiratory syndrome coronavirus 2 antigen vaccination
^ESCT1421498	Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen
^ESCT1421499	2019-nCoV (novel coronavirus) antigen vaccination
^ESCT1423116	COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc)
^ESCT1423124	COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd)
^ESCT1428110	COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose solution for injection multidose vials (Janssen-Cilag Ltd)
^ESCT1428343	Administration of fourth dose of 2019-nCoV (novel coronavirus) vaccine
^ESCT1428349	Administration of fifth dose of 2019-nCoV (novel coronavirus) vaccine
^ESCT1428355	Administration of third dose of 2019-nCoV (novel coronavirus) vaccine
^ESCT1431765	COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)
^ESCT1431769	Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd)
^ESCT1431777	COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd)
^ESCT1431787	Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc)
^ESCT1434508	CoronaVac COVID-19 Vaccine (adjuvanted) 600U/0.5ml dose suspension for injection vials (Sinovac Life Sciences)
^ESCT1434594	COVID-19 Vaccine Sinopharm BIBP (inactivated adjuvanted) 6.5U/0.5ml dose suspension for injection vials (Beijing Institute of Biological Products)
^ESCT1434687	COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India)
^ESCT1435624	Comirnaty Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd)
^ESCT1439300	COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)
^ESCT1441243	COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.)